NextRNA Therapeutics was founded in 2020 to pursue non-coding RNAs as a new class of therapeutic target for diseases including cancer, infectious diseases, and autoimmune disorders.
There are many RNAs that do not make proteins, called non-coding RNAs (ncRNA). These ncRNAs are able to regulate essential processes and when altered cause disease. NextRNA has developed an integrated drug discovery pipeline to identify and discover drugs for disease-causing ncRNAs.
For many ncRNAs, their function depends on direct interactions with proteins. NextRNA has developed and optimized a high-throughput screening platform to discover RNA-protein interactions and screen for molecules that disrupt these disease-relevant interactions. This platform is a key element in an integrated drug discovery pipeline that combines informatic tools, traditional methods, and novel approaches to develop RNA-directed therapies.
Originally developed in the Novina Lab at the Dana-Farber Cancer Institute, the company says its approach has the potential to address a broad range of diseases including cancer, infectious diseases, and autoimmune disorders.
Subscribe for alerts on new companies featured on Startups.Bio
U-Ploid Biotechnologies aims to revolutionize IVF for Age-Related Infertility. Millions of women around the world face the emotional and financial toll of age-related infertility. As …
BioTryp Therapeutics is University of Cambridge spin-out biotechnology company that focuses on the development of small molecules to inhibit biofilm formation, which causes 80% of …
Bastion Therapeutics is a pre-clinical stage biotechnology company focused on developing best-in-class Treg cell therapies, which can target the root causes of inflammatory disorders and …
HOVANA is a digital biology company tackling translational dysfunction as a driver of serious diseases. Leveraging insights into cellular reprogramming, HOVANA is inventing a new …
Founded in 2022, Couragene is a biotechnology company developing first-in-class in vivo genetic therapies using its proprietary delivery platforms. The company's technology holds potential for …
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer in unprecedented and patient-specific detail. By moving beyond …
